A 68-year-old man with paroxysmal nonvalvular atrial fibrillation, hypertension, and diabetes has a CHA₂DS₂-VASc score of 3 and normal renal function (eGFR 70 mL/min/1.73 m²). He has no history of bleeding and no mechanical valves. Which long-term strategy best reduces his stroke risk?